‘What Happens Next?’: Is It Time to Join the Psychedelic Renaissance?

Press/Media: Blogs, Podcasts and Social MediaPodcasts

Description

Attitudes towards psychoactive drugs for the treatment of mental health are changing, and for good reason – it’s hard to disagree with the evidence of the therapeutic benefits. Compelling studies are being conducted around the world, several of them here at Monash. And it won’t be long until you see the results of these studies for yourself – experts suggest health care providers could begin prescribing psychedelic drugs for PTSD patients as soon as 2023.

Period22 Oct 2021

Media contributions

1

Media contributions

  • Title‘What Happens Next?’: Is It Time to Join the Psychedelic Renaissance?
    Media name/outletLens
    Media typeOther
    Duration/Length/Size21 mins
    Country/TerritoryAustralia
    Date22/10/21
    DescriptionAttitudes towards psychoactive drugs for the treatment of mental health are changing, and for good reason – it’s hard to disagree with the evidence of the therapeutic benefits. Compelling studies are being conducted around the world, several of them here at Monash. And it won’t be long until you see the results of these studies for yourself – experts suggest health care providers could begin prescribing psychedelic drugs for PTSD patients as soon as 2023.
    Producer/AuthorMonash University
    URLhttps://lens.monash.edu/@what-happens-next/2021/10/21/1383968/whnpodcast-psychedelics-part-2
    PersonsPaul Liknaitzky